RealSeq Biosciences Awarded Patent for Innovative RNA Sequencing Method
SANTA CRUZ, CA, USA, May 21, 2024 /EINPresswire.com/ — RealSeq Biosciences is thrilled to announce that the United States Patent and Trademark Office has awarded the company U.S. Patent No. 11,964,997 B2 for its groundbreaking RNA sequencing technology. This innovative... Read More →
Saving Lives With Limula’s Machine For Industrializing Cell Therapy
“When you’re in the early stages of a gold rush, it makes sense to be the one providing the tools,” says Luc Henry, co-founder of Limula. The Swiss start-up, which is today announcing a $6.8 million funding round, wants to play... Read More →
Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials
Parkwalk Advisors led the latest funding round investing £4.2 million alongside Norcliffe Capital, The University of Oxford, Oxford Science Enterprises (OSE) and Vulpes Investment Management. Oxford Endovascular today announces the successful completion of an 8 million GBP Series A+ funding... Read More →
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling featuring CellChorus
Chimeric antigen receptor (CAR) T cells used for the treatment of B cell malignancies can identify T cell subsets with superior clinical activity. Here, using infusion products of individuals with large B cell lymphoma, we integrated functional profiling using timelapse... Read More →
Celldom Lands $938K Phase II SBIR Grant From NCI
NEW YORK – Cell analysis firm Celldom said Tuesday that it has won a $938,647 Phase II Small Business Innovation Research grant from the National Cancer Institute. In an email, CEO and Cofounder Ben Yellen said the grant will fund development of... Read More →
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
BOSTON, May 14, 2024 (GLOBE NEWSWIRE) — MEACOR Inc. is pleased to announce the successful closing of its $15 million Series A funding round. This substantial investment supports MEACOR’s mission to offer a novel transcatheter approach for the treatment of... Read More →
May Health Raises $25 Million in Series B Funding to Advance Development for Ovarian Rebalancing Therapy
– Bpifrance and Trill Impact Ventures co-led the round, joining founding investor Sofinnova Partners, to support the company’s pivotal REBALANCE study evaluating Ovarian Rebalancing in women with infertility caused by PCOS PARIS, May 13, 2024–May Health, a clinical-stage medical device... Read More →
CLEW Medical Scores FDA Clearance for Next-Gen AI-Powered Patient Deterioration Prediction
– CLEW Medical, a provider of AI-driven clinical surveillance and predictive analytics, has achieved a breakthrough with FDA 510(k) clearance for its second-generation AI models for predicting patient deterioration. – The FDA clearance builds upon their pioneering achievement of being the first FDA-cleared... Read More →
Meet the medical device company that won a $100,000 business pitch competition featuring SafePush
A Metairie-based company that makes disposable devices to regulate the flow of medication won the Baton Rouge Entrepreneurship Week business pitch competition Thursday evening. SafePush took home the $100,000 investment prize and earned a spot in October’s Startup World Cup Grand... Read More →
Healionics Awarded $1.25M NIH Grant to Support Commercialization of STARgraft Vascular Graft
SEATTLE, WASHINGTON, USA, May 9, 2024 /EINPresswire.com/ — Healionics Corporation, a developer of biomaterial-based medical devices, today announced it has been awarded a $1.25 million Small Business Innovation Research grant by the National Heart, Lung, and Blood Institute to support... Read More →